Herbas VPB

Print
EN | LT
LT - SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS
EN - SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/7034
A61K 31/551
A61K 31/4515
A61P 3/04
A61P 3/06
A61P 3/08
European patent
(11) Number of the document 2714052
(13) Kind of document T
(96) European patent application number 12724631.2
Date of filing the European patent application 2012-05-31
(97) Date of publication of the European application 2014-04-09
(45) Date of publication and mention of the grant of the patent 2018-09-19
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2012/060194
Date 2012-05-31
PCT application publication
(87) Number WO 2012/163990
Date 2012-12-06
Priority applications
(30) Number Date Country code
11168641 2011-06-03 EP
12153052 2012-01-30 EP
Inventors
(72)
WIENRICH, Marion, DE
MAYOUX, Eric, DE
Grantee
(73) Boehringer Ingelheim International GmbH, Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Title
(54) SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS
  SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS
Last update date 2021-04-30